PTGS2 and breast carcinoma: Previous studies with COX-2 overexpressing breast cancer cells and chemotherapy resistant breast cancer cells suggest that the high COX-2 expression in Gln-ind cells may account for their resistance to chemotherapeutic drugs [26], [30].